Cancer-associated thrombosis is a leading cause of non-cancer death in cancer patients
and is comprised of both arterial and venous thromboembolism (VTE). There are multiple …

The systemic spread of malignancies and the risk of cancer-associated thrombosis are
major clinical challenges in cancer therapy worldwide. As an important post-translational …

АВ—атриовентрикулярный (ая) АГ—артериальная гипертензия АД—артериальное
давление АТ—артериальный тромбоз АТО—атеротромботические осложнения АТФ …

Current recommended risk scores to predict thrombotic events associated with
myeloproliferative neoplasms (MPN) do not discriminate between arterial and venous …

Cancer-associated thrombocytosis and high concentrations of circulating transforming
growth factor–β1 (TGF-β1) are frequently observed in patients with progressive cancers …

Thrombotic diseases seriously endanger human health, neutrophils and neutrophil
extracellular traps (NETs) play an important role in abnormal thrombus formation. NETs are …

Although platelets are critically involved in thrombosis and hemostasis, experimental and
clinical evidence indicate that platelets promote tumor progression and metastasis through a …

Inflammatory proteins activate platelets, which have been observed to be directly related to
cancer progression and development. The aim of this systematic review is to investigate the …

The rising incidence and persistent thrombosis in multiple cancers including those that are
immunosuppressive highlight the need for understanding the tumor coagulome system and …

Objective Although the significance of increased plasma D-dimer levels in activating
coagulation and fibrinolysis has been reported, it is still controversial whether it can be used …